Latest Memphasys (ASX:MEM) News
Page 6
Page 6 of 7
Memphasys Boosts Japan Presence with Repeat Felix™ Order from Nishitan Clinic
24 Oct 2025
Memphasys Flags $1.1M R&D Tax Liability Amid ASX Scrutiny
20 Oct 2025
Memphasys Launches $1.12M Entitlement Offer to Accelerate Felix™ Commercialisation
2 Oct 2025
Memphasys Flags $1.12M R&D Tax Liability Amid Compliance Questions
30 Sept 2025
Memphasys Accelerates Felix IVF Tech with Middle East Deal and Capital Raise
25 Sept 2025
Memphasys Raises $0.84m, Slashes Costs 40% to Boost Felix™ Rollout
22 Sept 2025
Memphasys Expands ITL Deal, Eyes EU Market with Turkey Entry
18 Sept 2025
Memphasys Secures Exclusive $325K Middle East Deal to Boost Felix™ Growth
8 Sept 2025
Memphasys Advances Felix System Commercialisation Amid FY25 AUD 4.94M Loss
29 Aug 2025
Memphasys Accelerates Growth with Direct Sales and IVF Innovation
8 Aug 2025
Memphasys Advances Felix™ CE Mark, Boosts Sales in Japan, Validates RoXsta™ Assay
30 July 2025
Memphasys Advances Global IVF Market Entry with Felix™ CE Mark Submission
30 June 2025